2019
DOI: 10.1016/j.amjmed.2018.07.034
|View full text |Cite
|
Sign up to set email alerts
|

A Missing Link: Sarcoid-Lymphoma Syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 16 publications
0
5
0
Order By: Relevance
“…So, the question is: was the spleen biopsy misleading or did the patient have sarcoid-lymphoma syndrome? [4,11] . A multicentre Italian study reported experience with percutaneous ultrasound-guided fine needle aspiration biopsy of the spleen in 398 patients [12] .…”
Section: Discussionmentioning
confidence: 99%
“…So, the question is: was the spleen biopsy misleading or did the patient have sarcoid-lymphoma syndrome? [4,11] . A multicentre Italian study reported experience with percutaneous ultrasound-guided fine needle aspiration biopsy of the spleen in 398 patients [12] .…”
Section: Discussionmentioning
confidence: 99%
“…However, of interest is the simultaneous or consecutive presentation of sarcoidosis and lymphoma in the same patient (Brincker, 1986;Brincker, 1989;Kumthekar et al, 2019;Oskuei et al, 2017;Papanikolaou & Sharma, 2010). Various groups of investigators support the thesis that there is a link between sarcoidosis and lymphoma (Karakantza et al, 1996).…”
Section: Discussionmentioning
confidence: 99%
“…There are a number of publications that examine the possibility of an association between sarcoidosis and lymphoproliferative diseases (LPD) (heterogeneous types of lymphoma) within the so-called sarcoid-lymphoma syndrome (Kumthekar, Raess, & Ghetie, 2019;Oskuei, Hicks, Ghaffar, & Hoffstein, 2017). In the presence of hilar/ mediastinal lymphadenopathy, both diseases should be considered in a differential diagnosis, but also the possibility of coexistence within the same patient should not be excluded (Oskuei et al, 2017).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Longstanding inflammation and immune dysregulation may be risk factors for developing malignancy [21]. Release of some inflammatory cytokines, activation of Th1/Th17 cells, decreased regulatory T-cells and impaired CD4 T-cells, may promote the proliferation of cells and blood vessels, tissue remodeling, and stromal growth leading to a tumor [22].…”
Section: Pathology Of Sarcoidosis Association With Other Disorders/malignancymentioning
confidence: 99%